Three per cent dextran-60 as a plasma substitute in blood component therapy. II. Comparative studies on pre- and postoperative blood volume.
(1985) In Acta Anaesthesiologica Scandinavica 29(8). p.775-781- Abstract
- Microaggregate-poor erythrocyte concentrate with 3% dextran-60 as a plasma substitute was compared with microaggregate-poor whole blood for replacement of intra-operative blood loss. Their blood volume-conserving effects were studied by sequential blood volume determination with radioactive technetium (99mTc) in 19 patients undergoing total hip arthroplasty. Pre-operatively there was no difference in blood volume between the groups. Immediately after surgery and on the 2nd postoperative day there was no difference in total blood volume. Blood component therapy with 3% dextran as a plasma substitute is an efficient principle for intra-operative blood loss replacement at hip operations.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3634428
- author
- Schött, Ulf LU ; Thorén, T ; Sjöstrand, U ; Berséus, O and Söderholm, B
- publishing date
- 1985
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Surgical Procedures, Serum Albumin: metabolism, Plasma Substitutes: therapeutic use, Hemorrhage: therapy, Blood Proteins: metabolism, Dextrans: therapeutic use, Operative: adverse effects, Technetium: diagnostic use
- in
- Acta Anaesthesiologica Scandinavica
- volume
- 29
- issue
- 8
- pages
- 775 - 781
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:2417435
- scopus:0022369386
- ISSN
- 0001-5172
- project
- Koagulation vid kirurgi och kritisk sjukdom
- language
- English
- LU publication?
- no
- id
- fc2bbf32-ae2c-4e35-8c4e-adcd233dc00f (old id 3634428)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/2417435?dopt=Abstract
- date added to LUP
- 2016-04-04 08:41:25
- date last changed
- 2021-01-03 06:08:40
@article{fc2bbf32-ae2c-4e35-8c4e-adcd233dc00f, abstract = {{Microaggregate-poor erythrocyte concentrate with 3% dextran-60 as a plasma substitute was compared with microaggregate-poor whole blood for replacement of intra-operative blood loss. Their blood volume-conserving effects were studied by sequential blood volume determination with radioactive technetium (99mTc) in 19 patients undergoing total hip arthroplasty. Pre-operatively there was no difference in blood volume between the groups. Immediately after surgery and on the 2nd postoperative day there was no difference in total blood volume. Blood component therapy with 3% dextran as a plasma substitute is an efficient principle for intra-operative blood loss replacement at hip operations.}}, author = {{Schött, Ulf and Thorén, T and Sjöstrand, U and Berséus, O and Söderholm, B}}, issn = {{0001-5172}}, keywords = {{Surgical Procedures; Serum Albumin: metabolism; Plasma Substitutes: therapeutic use; Hemorrhage: therapy; Blood Proteins: metabolism; Dextrans: therapeutic use; Operative: adverse effects; Technetium: diagnostic use}}, language = {{eng}}, number = {{8}}, pages = {{775--781}}, publisher = {{Wiley-Blackwell}}, series = {{Acta Anaesthesiologica Scandinavica}}, title = {{Three per cent dextran-60 as a plasma substitute in blood component therapy. II. Comparative studies on pre- and postoperative blood volume.}}, url = {{http://www.ncbi.nlm.nih.gov/pubmed/2417435?dopt=Abstract}}, volume = {{29}}, year = {{1985}}, }